PerkinElmer, Inc. Expands its Cellular Pathway and Biomarker Research Offerings to Aid in the Study of Multiple Disease States

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced the expansion of its “No Wash” ALPHA (Amplified Luminescent Proximity Homogeneous Assay) Technology portfolio. The Company is introducing 28 new highly sensitive cell signaling pathway and biomarker research assay kits, that provide researchers with rich data to help advance the study of diseases including cancer, inflammatory and neurodegenerative disorders.
MORE ON THIS TOPIC